Stay updated with breaking news from Immunization Practices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generated $397 million in full year 2023 revenues, including $275 million for SYFOVRE® and $91 million for EMPAVELI® Strong SYFOVRE launch, with more than 160,000 total doses distributed in 2023...
This continuously updated tracker shows Michigan's COVID-19 case numbers, positivity rate, county infection rates, and weekly cases along with maps and daily state curve data.
Moderna anticipates initial regulatory approvals for its RSV vaccine in first half of 2024.
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results ...
Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55Reports full-year revenues of $6.8 billion, GAAP net loss of $(4.7) billion and GAAP diluted EPS of $(12.33); loss primarily driven by mostly non-cash charges of $3.7 billion related to resizing and a tax valu...